GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
After GSK replaced a popular asthma inhaler with an identical product at a much higher price in order to avoid paying Medicaid rebates, many families reported substantial financial and treatment ...
Add Yahoo as a preferred source to see more of our stories on Google. A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of ...
Boston families with kids who rely on inhalers have been caught in the crossfire of a pharmaceutical shake-up, and a new Senate report says the fallout has not been theoretical. When GSK pulled the ...
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent ...
Preclinical data indicate that inhaled treprostinil may be useful for the treatment of idiopathic pulmonary fibrosis (IPF) through an antifibrotic mechanism, a premise that is supported by clinical ...
Glenmark is eligible for 180 days of CGT exclusivity upon commercialization of generic FloVent. FloVent HFA Inhalation Aerosol, 44 mcg had a market value of approximately $520.1 million. for the ...
FDA cleared Glenmark’s generic fluticasone propionate HFA as the first non–authorized generic equivalent to Flovent HFA, requiring pharmaceutical equivalence and comparable systemic exposure. Safety ...
Glenmark Pharmaceuticals is likely to remain in focus after its subsidiary, Glenmark Specialty SA, received final approval from the United States Food and Drug Administration (US FDA) for Fluticasone ...
ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of a generic of Flovent hydrofluoroalkane inhalation aerosol for the maintenance ...
The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday. Delivered as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results